Loading
Latest filing published 22 Nov 2010 for ADVANCIS PHARMACEUTICAL CORP.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
EGI-MBRK, L.L.C. discloses dealings in Advancis Pharmaceutical Corp to SEC (Form 4). In total, 3 filings cover trades dated from 17 December 2009 to 22 November 2010.
No open-market sale appears; the market trades are 1 purchase worth €579k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 22 November 2010 came the latest disclosure, a transaction in Advancis Pharmaceutical Corp. The clock since the last published purchase (21 December 2009) now reads 6,151 days. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations